Özlem Türeci, a renowned German physician, scientist, and entrepreneur, has made a profound impact in the field of biotechnology. In 2008, she co-founded BioNTech, a pioneering company that has revolutionized the development of vaccines. Her groundbreaking work led to the creation of the first messenger RNA-based vaccine approved for use against COVID-19 in 2020.
As BioNTech's chief medical officer since 2018, Türeci has played a crucial role in shaping the company's medical strategy. Her expertise has been instrumental in driving the company's mission to develop innovative treatments and vaccines.
In addition to her work at BioNTech, Türeci has also taken on a prestigious academic role. Since 2021, she has been appointed as Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. This appointment is a testament to her exceptional skills and knowledge in the field of immunotherapy.
Türeci's personal and professional achievements have been recognized with numerous awards. Her husband, Uğur Şahin, is also a renowned scientist and entrepreneur, and together they have made significant contributions to the field of biotechnology.
